Finch Therapeutics Group Inc

+0.11 (+1.30%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)405.93M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5 Million
Adjusted EPS-$0.32
See more estimates
10-Day MA$8.84
50-Day MA$11.50
200-Day MA$13.33
See more pivots

Finch Therapeutics Group Inc Stock, NASDAQ:FNCH

200 Inner Belt Road, Suite 400, Somerville, Massachusetts 02143
United States of America
Phone: +1.617.229.6499
Number of Employees: 131000


Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Somerville, MA.